Site navigation

Navigation

Breast cancer - capecitabine (replaced by CG81)

Guidance on the use of capecitabine for the treatment of locally advanced or metastatic breast cancer

Summary

This guidance has been updated and replaced by CG81 Advanced breast cancer.


Guidance documents

  • No documents found

Implementing this guidance

  • No documents found

About this guidance

Technology appraisals TA62

Issued: May 2003

See related guidance:

See this guidance in practice:

Order printed copies of this guidance